In this report, we address the possible role of insulin exposure in melanocyte transformation. To this aim, normal melanocytes were exposed to chronic insulin and glucose supplementation (twice the standard medium concentration) for at least 3 wk. After 3-wk treatment, melanocytes increased proliferation (doubling time: 2.7 vs. 5.6 days, P Ͻ 0.01). After 3-wk treatment or after 3-wk treatment followed by 4-wk reculture in standard medium, melanocytes were able to grow in soft agar colonies. Treated melanocytes had increased DNA content (ϩ8%, P Ͻ 0.05), chromosomal aberrations, and modified oncoprotein profile: p-Akt expression increased (ϩ32%, P Ͻ 0.01), Akt decreased, and c-Myc increased (ϩ40%, P Ͻ 0.05). PP2A protein expression increased (ϩ42, P Ͻ 0.05), while PP2A methylation decreased (Ϫ42%, P Ͻ 0.05), and PP2A activity was reduced (Ϫ27%, P Ͻ 0.05). PP2A transcription level was increased (ppp2r1a, PP2A subunit A, ϩ44%, P Ͻ 0.05). Also, transcriptomic data revealed modifications in insr (insulin receptors, ϩ10%, P Ͻ 0.05) and Il8 (inflammation protein, ϩ99%, P Ͻ 0.01). Glycolysis was modified with increased transcription of Pgk1 and Hif1a (P Ͻ 0.05), decreased transcription of Pfkfb3 (P Ͻ 0.05), decreased activity of pyruvate kinase (P Ͻ 0.01), and decreased pyruvate cell content as assessed by 1 H-NMR spectroscopy. In addition, methyl group metabolism was altered with decreased global DNA methylation (Ϫ51%, P Ͻ 0.01), increased cytosolic protein methylation (ϩ18%, P Ͻ 0.05), and consistent changes in methylated species on